Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KPNA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBPF26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SRP72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
G3BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSTNP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WTH3DI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF721 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NIPA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAUS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBPF10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UPF3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on